By Vincent C. AllaireNewsroom Human genome editing for both research and therapy is progressing, raising ethical questions among scientists around the world.
By Cynthia Lee Some drug regimens, such as those designed to eliminate tumors, are notorious for nasty side effects. Unwanted symptoms are often the result of medicine going where it’s not needed and harming healthy cells. To minimize this risk, researchers in Quebec have developed nanoparticles that only release a drug when exposed to near-infrared light, which doctors could beam onto a specific site. Their report appears in the Journal of the American Chemical Society.
By Chris Chipello, McGill Newsroom Study by McGill researchers assesses short-run impacts on households, industries The cost burden of Quebec’s carbon-pricing policy, is likely to be modest across income groups and industries, according to a McGill University research team.
Don't miss the January 15, 2016, edition of CBC Radio's Quirks and Quarks to learn how Prof Jeff Bergthorson and colleagues are finding ways for energy to be stored and transported via iron and other metals, a novel and potentially important method for delivering fossil-fuel-free power.
By Katherine Gombay, McGill Newsroom Failure to find active microbes in coldest Antarctic soils has implications for search for life on Mars
By Katherine Gombay, McGill Newsroom Brain uses “older” systems/structures to preferentially process emotion expressed through vocalizations
Gold nanoparticles have unusual optical, electronic and chemical properties, which scientists are seeking to put to use in a range of new technologies, from nanoelectronics to cancer treatments.
By Katherine Gombay, McGill Newsroom Arctic peoples inherently able to adapt given changes to various non-climatic factors
Drought and extreme heat events slashed cereal harvests in recent decades by 9% to 10% on average in affected countries – and the impact of these weather disasters was greatest in the developed nations of North America, Europe and Australasia, according to a new study led by researchers from McGill University and the University of British Columbia.
By Chris Chipello
University of Toronto and McGill University scientists are leading an international partnership to discover new and improved drug treatments for tuberculosis, malaria and neglected tropical diseases -- thanks to a contribution from Merck Canada Inc., as well as an additional $5 million supplement to a grant from the Bill & Melinda Gates Foundation. The new funding brings the total investment from the Bill & Melinda Gates Foundation to nearly US $12 million since 2012.
Now, an international team of researchers led by McMaster University in collaboration with the Research Institute of the McGill University Health Centre has found that soap and water is actually less effective than just using saline water. The findings, which were published in the New England Journal of Medicine, could lead to significant cost savings, particularly in developing countries where open fractures are particularly common.
« La demande était pas mal corpo au début, » says Alain Farah with a laugh. He is anything but. Farah teaches in the department of French languages and literature at McGill. He’s also the author of a novel called Pourquoi Bologne that came out in French in 2013 and appeared in English in 2015 under the title Ravenscrag. The work tells a fractured, spinning kind of story about a writer called Alain Farah who works at McGill in 1962 and in 2012. In the novel, there are episodes, both in 1962 and 2012, where the character Alain Farah wanders around the McGill campus, clearly in bad shape.